| Primary |
| Essential Hypertension |
100.0% |
|
| Orthostatic Hypotension |
100.0% |
|
| Secondary |
| Product Used For Unknown Indication |
31.8% |
| Drug Use For Unknown Indication |
25.0% |
| Pain |
6.7% |
| Neuralgia |
5.5% |
| Depression |
4.9% |
| Prophylaxis |
3.4% |
| Anxiety |
3.3% |
| Extragonadal Primary Germ Cell Tumour Mixed Stage I |
2.3% |
| Cancer Pain |
2.2% |
| Hypertension |
2.0% |
| Intentional Overdose |
1.7% |
| Major Depression |
1.6% |
| Agitation |
1.5% |
| Nausea |
1.3% |
| Back Pain |
1.2% |
| Febrile Bone Marrow Aplasia |
1.1% |
| Procedural Pain |
1.1% |
| Psychotic Disorder |
1.1% |
| Essential Hypertension |
1.0% |
| Chest Pain |
1.0% |
|
| Orthostatic Hypotension |
10.1% |
| Neutropenia |
7.0% |
| Somnolence |
7.0% |
| Sopor |
6.2% |
| Suicide Attempt |
6.2% |
| Urinary Retention |
6.2% |
| Overdose |
5.4% |
| Toxicity To Various Agents |
5.4% |
| Hepatocellular Injury |
4.7% |
| Pancreatitis Acute |
4.7% |
| Road Traffic Accident |
4.7% |
| Fall |
3.9% |
| Febrile Bone Marrow Aplasia |
3.9% |
| Hyponatraemia |
3.9% |
| Intestinal Obstruction |
3.9% |
| Tremor |
3.9% |
| Vomiting |
3.9% |
| Malaise |
3.1% |
| Peripheral Sensory Neuropathy |
3.1% |
| Renal Failure |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Drug Use For Unknown Indication |
20.4% |
| Depression |
8.3% |
| Hiv Infection |
7.3% |
| Pain |
5.7% |
| Neuralgia |
3.9% |
| Hypertension |
3.6% |
| Rhabdomyosarcoma |
3.1% |
| Rheumatoid Arthritis |
3.1% |
| Bronchopneumopathy |
2.7% |
| Anxiety |
2.4% |
| Multiple Sclerosis |
2.4% |
| Insomnia |
2.2% |
| Prophylaxis |
1.7% |
| Osteoporosis |
1.5% |
| Osteitis |
1.5% |
| Back Pain |
1.4% |
| Diabetes Mellitus |
1.3% |
| Bronchopulmonary Aspergillosis |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
|
| Thrombocytopenia |
9.2% |
| Weight Decreased |
8.6% |
| Vomiting |
8.0% |
| Renal Failure Acute |
7.5% |
| Somnolence |
6.9% |
| Weight Increased |
6.9% |
| Neutropenia |
6.3% |
| Pyrexia |
5.2% |
| Sudden Death |
4.6% |
| Vertigo |
4.6% |
| Mucosal Inflammation |
4.0% |
| Urinary Retention |
4.0% |
| Malaise |
3.4% |
| Nausea |
3.4% |
| Hepatocellular Injury |
2.9% |
| Pulmonary Embolism |
2.9% |
| Rash Maculo-papular |
2.9% |
| Renal Failure |
2.9% |
| Sensorimotor Disorder |
2.9% |
| Toxic Skin Eruption |
2.9% |
|
| Interacting |
| Depression |
14.3% |
| Drug Use For Unknown Indication |
14.3% |
| Neuralgia |
14.3% |
| Chest Pain |
9.5% |
| Intentional Overdose |
9.5% |
| Pain |
7.1% |
| Anxiety |
4.8% |
| Cardiac Flutter |
4.8% |
| Essential Hypertension |
4.8% |
| Hypertension |
4.8% |
| Impulsive Behaviour |
4.8% |
| Atrial Fibrillation |
2.4% |
| Insomnia |
2.4% |
| Pulmonary Embolism |
2.4% |
|
| Orthostatic Hypotension |
22.2% |
| Drug Interaction |
11.1% |
| Road Traffic Accident |
11.1% |
| Ventricular Dysfunction |
11.1% |
| Ventricular Tachycardia |
11.1% |
| Joint Dislocation |
5.6% |
| Renal Failure Acute |
5.6% |
| Respiratory Distress |
5.6% |
| Respiratory Failure |
5.6% |
| Toxicity To Various Agents |
5.6% |
| Urinary Tract Infection |
5.6% |
|
